Compliance takeaways from FDA’s final ‘intended use’ rule
By 
Jaclyn Jaeger2021-09-07T19:08:00
The U.S. Food and Drug Administration’s “intended use” final rule reaffirms the agency’s wide latitude of discretion in establishing an off-label use case against pharmaceutical and medical device companies.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefFDA bans Red No. 3 dye after decades of concerns over possible health risks
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
-
OpinionWhen AI acts: The compliance challenge of agentic systems
Artificial intelligence is no longer limited to generating insights or supporting analysis. With every passing day, AI systems are being designed to initiate actions, trigger workflows, and influence outcomes with minimal human intervention.
-
ArticleFalse Claims Act enforcement themes for 2026
The U.S. Department of Justice touted a record $6.8 billion in False Claims Act (FCA) recoveries in fiscal year 2025, much of that total stems from prior years’ cases and does not necessarily reflect the administration’s current enforcement direction.
More from Regulatory Policy
-
ArticleU.K. listed companies must adapt to new sustainability reporting regime by 2027
Sustainability reporting rules for U.K. listed companies are set to change. The U.K. financial regulator has launched a consultation laying out its proposals, which aim to align the reporting regime with the international ISSB standards.
-
ArticleU.K. ‘buy now pay later’ regulation signals end of ‘Wild West’ fintech loans system
Firms offering “buy now, pay later” financing will become part of the regulated financial services sector in the U.K. from July 15. Compliance teams must act now to ensure they are ready to introduce rules and establish creditworthiness assessment processes, adapt systems, and change data processes before the deadline.
-
ArticleNew EU rules will force companies to come clean on pay
New rules that will be introduced this June will require companies based in the European Union (EU) to explain why some workers are paid more money for the same job and remedy any “unjustified” discrepancies.